{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:52:15Z","timestamp":1793407935594,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011087","name":"Society of Interventional Radiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA233878"],"award-info":[{"award-number":["R01CA233878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jvir.2022.12.021","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T02:11:48Z","timestamp":1670897508000},"page":"362-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Yttrium-90 Radiation Segmentectomy in Oligometastatic Secondary Hepatic Malignancies"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrew M.","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-2270","authenticated-orcid":false,"given":"Rohan","family":"Savoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent T.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Hohlastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-1825","authenticated-orcid":false,"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-788X","authenticated-orcid":false,"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2022.12.021_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jvir.2017.08.021","article-title":"Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control","volume":"29","author":"Shady","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.12.021_bib2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/01.RVI.0000179815.44868.66","article-title":"90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging","volume":"16","author":"Lewandowski","year":"2005","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.12.021_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2022.12.021_bib4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2022.12.021_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2022.12.021_bib6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2022.12.021_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2022.12.021_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.21037\/jgo.2017.11.02","article-title":"Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases","volume":"9","author":"Meiers","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jso.26223","article-title":"Yttrium-90 radiation segmentectomy for hepatic metastases: a multi-institutional study of safety and efficacy","volume":"123","author":"Padia","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib10","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1007\/s00261-021-02956-6","article-title":"Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres","volume":"46","author":"Kurilova","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jvir.2022.12.021_bib11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.12.021_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","article-title":"Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics","volume":"17","author":"Salem","year":"2006","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.12.021_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-013-2575-8","article-title":"Sustained safety and efficacy of extended-shelf-life 90Y glass microspheres: long-term follow-up in a 134-patient cohort","volume":"41","author":"Lewandowski","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2022.12.021_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jvir.2010.10.029","article-title":"Research reporting standards for radioembolization of hepatic malignancies","volume":"22","author":"Salem","year":"2011","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.12.021_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2014.00198","article-title":"Side effects of yttrium-90 radioembolization","volume":"4","author":"Riaz","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2022.12.021_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2010.262","article-title":"Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma","volume":"303","author":"Riaz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jvir.2022.12.021_bib18","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.18632\/oncotarget.3455","article-title":"The biology and treatment of oligometastatic cancer","volume":"6","author":"Reyes","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jvir.2022.12.021_bib19","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1200\/JCO.2004.00.6155","article-title":"Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?","volume":"23","author":"Khatri","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib20","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2022.12.021_bib21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2022.12.021_bib22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/archsurg.143.12.1204","article-title":"Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation","volume":"143","author":"Gleisner","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.jvir.2022.12.021_bib23","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1245\/s10434-014-3817-0","article-title":"A\u00a0retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases","volume":"21","author":"Correa-Gallego","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1245\/s10434-011-2048-x","article-title":"Patterns of recurrence after ablation of colorectal cancer liver metastases","volume":"19","author":"Kingham","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ejca.2013.12.008","article-title":"Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983","volume":"50","author":"Tanis","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2022.12.021_bib26","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fonc.2019.01052","article-title":"Ablation or resection for colorectal liver metastases? A systematic review of the literature","volume":"9","author":"Kron","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jjco\/hyl027","article-title":"Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis","volume":"36","author":"Takahashi","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.3501","article-title":"Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)","volume":"33","author":"Ruers","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib29","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)","volume":"23","author":"Ruers","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib30","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2022.12.021_bib31","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.12.021_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jvir.2013.11.005","article-title":"Outpatient single-session yttrium-90 glass microsphere radioembolization","volume":"25","author":"Gates","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432201418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432201418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:10:22Z","timestamp":1760940622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105104432201418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S105104432201418X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2022.12.021","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yttrium-90 Radiation Segmentectomy in Oligometastatic Secondary Hepatic Malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2022.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2022","name":"copyright","label":"Copyright"}]}}